#dmdgene — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #dmdgene, aggregated by home.social.
-
https://www.europesays.com/uk/570996/ Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information #AcuteLiverFailure #AmbulatoryPatients #DMDGene #DuchenneMuscularDystrophy #ELEVIDYS #Health #IntravenousInfusion #LiverInjury #Medication #PrescribingInformation #SareptaTherapeutics #UK #UnitedKingdom
-
Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information
CAMBRIDGE, Mass., November 14, 2025–(BUSINESS WIRE)–Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases,…
#NewsBeep #News #Medication #acuteliverfailure #ambulatorypatients #CA #Canada #DMDgene #duchennemusculardystrophy #ELEVIDYS #Health #intravenousinfusion #Liverinjury #prescribinginformation #sareptatherapeutics
https://www.newsbeep.com/ca/283661/ -
Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information
CAMBRIDGE, Mass., November 14, 2025–(BUSINESS WIRE)–Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for …
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #acuteliverfailure #ambulatorypatients #DMDgene #duchennemusculardystrophy #ELEVIDYS #Health #intravenousinfusion #Liverinjury #prescribinginformation #SareptaTherapeutics
https://www.newsbeep.com/us/292160/ -
Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information
CAMBRIDGE, Mass., November 14, 2025–(BUSINESS WIRE)–Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for …
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #acuteliverfailure #ambulatorypatients #DMDgene #duchennemusculardystrophy #ELEVIDYS #Health #intravenousinfusion #Liverinjury #prescribinginformation #SareptaTherapeutics
https://www.newsbeep.com/us/292160/ -
Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information
CAMBRIDGE, Mass., November 14, 2025–(BUSINESS WIRE)–Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases,…
#NewsBeep #News #Medication #acuteliverfailure #ambulatorypatients #DMDgene #duchennemusculardystrophy #ELEVIDYS #Health #intravenousinfusion #Liverinjury #prescribinginformation #sareptatherapeutics #UK #UnitedKingdom
https://www.newsbeep.com/uk/263365/ -
https://www.europesays.com/ie/181196/ Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information #AcuteLiverFailure #AmbulatoryPatients #DMDGene #DuchenneMuscularDystrophy #Éire #ELEVIDYS #Health #IE #IntravenousInfusion #Ireland #LiverInjury #Medication #PrescribingInformation #SareptaTherapeutics